For the tumor suppressor genes, ES-fusion brought about normalization of p19ARFand p16INK4a levels, from undetectable levels in the adult cancer cells (Hep1-6 and B16) or from comparatively high levels in the embryonic carcinomas (P19 and F9) (Figure 2e). This evidence concerns the gene CDKN2A and cancer.